Signals
Platform Powered By EquityPandit

Cash Intraday
Signals

Option
Signals

Stock Future
Intraday Signals

Swing Trading
Signals

Investment
Opportunities

Stock
Signals

Join Now

Glenmark Pharmaceuticals Ltd

NSE :GLENMARK   BSE :532296  Sector : Pharmaceuticals
Buy, Sell or Hold GLENMARK? Ask The Analyst

BSE

prev close

OPEN PRICE

bid price (qty)

offer price (qty)

volume

Today's low / high

52 WK low / high

NSE

prev close

open price

bid price (qty)

offer price (qty)

volume

Today's' low / high

52 WK low / high

14 Nov
1533.70
(-0.37%)
13 Nov
1539.40
(-2.39%)
12 Nov
1577.05
(-3.50%)
11 Nov
1634.20
(-1.94%)
08 Nov
1666.50
(0.55%)
07 Nov
1657.35
(-6.31%)
06 Nov
1768.95
(2.54%)
05 Nov
1725.15
(1.52%)
04 Nov
1699.25
(0.53%)
01 Nov
1690.30
(-0.25%)
31 Oct
1694.55
(1.47%)
30 Oct
1670.00
(-0.30%)
29 Oct
1675.10
(-2.24%)
28 Oct
1713.50
(2.99%)
25 Oct
1663.80
(-0.64%)
24 Oct
1674.55
(-0.67%)
23 Oct
1685.90
(0.22%)
22 Oct
1682.25
(-2.01%)
21 Oct
1716.80
(-1.25%)
18 Oct
1738.45
(0.18%)
17 Oct
1735.30
(-2.59%)

Price Chart Historical Data Technical Chart

Technical Analysis

Short Term Investors

Very Bearish
Medium Term Investors

Very Bearish
Long Term Investors

Bullish

Moving Averages

5 DMA
Bearish

1589.53

10 DMA
Bearish

1649.03

20 DMA
Bearish

1670.12

50 DMA
Bearish

1697.07

100 DMA
Bearish

1582.01

200 DMA
Bullish

1296.21


Intraday Support and Resistance
(Based on Pivot Points) |

Updated On Nov 14, 2024 04:00 PM For Next Trading Session

Pivots Classic Fibonacci Camarilla Woodie DM
R3 1590.46 1575.23 1543.6 - -
R2 1575.23 1561.48 1540.3 1573.85 -
R1 1554.46 1552.98 1537 1551.7 1564.85
P 1539.23 1539.23 1539.23 1537.85 1544.43
S1 1518.46 1525.48 1530.4 1515.7 1528.85
S2 1503.23 1516.98 1527.1 1501.85 -
S3 1482.46 1503.23 1523.8 - -

Key Metrics

EPS

57.32

P/E

26.72

P/B

1.88

Dividend Yield

0.16%

Market Cap

43,279 Cr.

Face Value

1

Book Value

814.02

ROE

-50.87%

EBITDA Growth

640.33 Cr.

Debt/Equity

0.34

Shareholding Pattern

  46.65% Total Promoter Holding
11.41% Mutual Fund Holdings
23.05% FIIs
17.06% Non Institution
0.7% Insurance Companies
0% Custodians
1.13% Other Parties

Shareholding History

Quarterly Result (Figures in Rs. Crores)


Glenmark Pharmaceuticals Ltd Quaterly Results


Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
INCOME 3327.81 2670.88 3860.49 3275.68 3473.21
PROFIT 68.79 -393.41 -2285.2 340.27 354.21
EPS -2.9 -12.45 -43.17 12.06 12.55

Glenmark Pharmaceuticals Ltd Quaterly Results


Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
INCOME 2306.99 1623.91 8081.41 2385.19 2719.18
PROFIT 317.62 4.87 841.36 453.73 595.06
EPS 10.72 -0.72 163.5 16.08 21.09

Profit & Loss (Figures in Rs. Crores)


Glenmark Pharmaceuticals Ltd Profit & Loss


Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
INCOME 6943.01 7721.83 9576.39 9032.11 10299.46 10705.37 11227.94 12482.71 12579.76 13246.04
PROFIT 263.52 743.05 1155.03 805.34 818.68 755.72 941.32 1107.67 609.68 -4473.72
EPS 7.3 26.33 39.29 28.49 32.78 27.5 34.38 35.21 13.37 -50.8

Glenmark Pharmaceuticals Ltd Profit & Loss


Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
INCOME 5358.49 6306 8220.99 5709.21 6787.67 7289.2 8032.82 9202.67 9237.97 14232.55
PROFIT 1139.79 1484.9 2322 1016.26 1344.95 1340.12 1589.58 1643.77 1578.33 1425.03
EPS 36.72 52.6 75.86 35.95 57.49 48 58.46 70.8 42.84 183.11

Balance Sheet (Figures in Rs. Crores)

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
SOURCES OF FUNDS :
Share Capital 28.2228.2228.2228.2228.2228.2228.2228.2228.2227.13
Reserves Total 7,819.719,445.719,058.437,036.416,042.295,576.975,135.264,464.313,601.421,756.36
Total Shareholders Funds7,847.939,473.939,086.657,064.636,070.515,605.195,163.484,492.533,629.641,783.49
Minority Interest-0.38365.34351.47-0.35-0.39-0.38-0.37-0.42-0.3-0.19
Secured Loans 000006.1119.742.5915.5336.69
Unsecured Loans 1,230.934,607.883,962.024,985.724,868.634,442.564,619.644,721.063,972.583,763.24
Total Debt1,230.934,607.883,962.024,985.724,868.634,448.674,639.384,723.653,988.113,799.93
Other Liabilities540.52397.59152.5196.68429.2789.142.632.7476.99121.92
Total Liabilities9,61914,844.7413,552.6412,246.6811,368.0210,142.629,805.099,248.57,694.445,705.15
APPLICATION OF FUNDS :
Gross Block 9,619.6410,359.5910,213.478,731.588,269.836,527.275,367.954,769.924,300.543,495.47
Less: Accumulated Depreciation5,409.484,937.834,326.233,602.733,241.282,857.012,338.42,014.831,706.991,480.09
Net Block4,210.165,421.765,887.245,128.855,028.553,670.263,029.552,755.092,593.552,015.38
Capital Work in Progress661.881,189.641,009.871,381.671,221.891,398.941,121.87708.11542.8477.13
Investments 789.6644.5749.6224.6324.5929.6614.6615.6917.217.12
Inventories 2,513.052,373.622,499.832,276.832,135.622,252.072,030.592,139.051,567.761,269.04
Sundry Debtors 1,858.413,665.173,101.142,572.062,408.962,194.592,331.812,404.322,492.652,511.77
Cash and Bank Balance1,659.461,160.31,411.521,139.161,111.24937.771,234.691,057.66857.12775.88
Loans and Advances 1,397.173,526.441,269.871,371.541,147.781,312.41,391.611,273.61986.77774.38
Total Current Assets7,428.0810,725.538,282.357,359.586,803.616,696.836,988.696,874.645,904.35,331.07
Current Liabilities 3,807.273,935.932,914.642,763.72,744.432,662.082,357.822,252.412,364.422,334.38
Provisions 932.08590.51584.5564.45555.91484.11432.46262.95134.03216.78
Total Current Liabilities & Provisions4,739.354,526.443,499.143,328.163,300.343,146.182,790.282,515.362,498.442,551.16
Net Current Assets2,688.746,199.094,783.214,031.423,503.273,550.654,198.414,359.273,405.862,779.91
Deferred Tax Assets1,049.721,805.911,969.551,852.181,770.851,761.631,728.581,553.351,274.96169.73
Deferred Tax Liability0.280.51314.93346.26331.59378.68408.32242.08210.07222.52
Net Deferred Tax1,049.441,805.41,654.621,505.921,439.261,382.951,320.261,311.271,064.89-52.79
Other Assets219.11184.27168.08174.18150.45110.16120.3499.0670.15468.42
Total Assets9,618.9914,844.7313,552.6512,246.6711,368.0110,142.619,805.099,248.497,694.445,705.16
Contingent Liabilities1,063.3336.69361.31384.2271.2173.5147.136.8836.89129.37
Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
SOURCES OF FUNDS :
Share Capital 28.2228.2228.2228.2228.2228.2228.2228.2228.2227.13
Reserves Total 22,942.417,849.2516,710.3714,781.2913,198.0511,913.8710,363.229,408.47,337.754,924.92
Total Shareholders Funds22,970.6217,877.4716,738.5914,809.5113,226.2711,942.0910,391.449,436.627,365.974,952.05
Secured Loans 000006.1119.742.5915.5336.69
Unsecured Loans 707.293,221.223,737.73,703.993,573.763,128.372,961.332,773.94771.89373.41
Total Debt707.293,221.223,737.73,703.993,573.763,134.482,981.072,776.53787.42410.1
Other Liabilities131.94372.58121.32136.61205.6588.512.62.414.7121.92
Total Liabilities23,809.8521,471.2720,597.6118,650.1117,005.6815,165.0813,375.1112,215.568,158.095,484.07
APPLICATION OF FUNDS :
Gross Block 3,392.753,183.653,026.282,848.562,595.062,260.12,581.752,368.532,107.041,801.98
Less : Accumulated Depreciation 1,636.51,437.71,273.951,126.07983.11846.62882.63772.16669.04571.3
Net Block 1,756.251,745.951,752.331,722.491,611.951,413.481,699.121,596.371,4381,230.68
Capital Work in Progress197.67172.34109.04131.4200.01286.2419.68270.66276.06294.19
Investments 12,964.7910,332.718,559.396,989.954,713.933,268.753,212.681,866.71,858.431,659.52
Inventories 1,142.691,090.21951.66762.39837.5911.211,111.181,145.06968736.63
Sundry Debtors 2,484.472,505.662,678.322,488.751,835.242,087.133,828.913,879.43,057.662,440.83
Cash and Bank Balance129.1593.7929.6315.7988.26256.48177.38252.1874.2448.55
Loans and Advances 925.17696.82743.311,642.21,662.891,886.33757.78674.19528.03371.94
Total Current Assets4,681.484,386.484,402.934,909.124,423.895,141.155,875.255,950.834,627.933,597.95
Current Liabilities 3,249.792,952.142,168.391,834.311,827.481,855.861,796.561,727.021,867.561,882.99
Provisions 354.74162.52148.49133.11118.45121.7593.257.9787.37151.38
Total Current Liabilities & Provisions3,604.543,114.662,316.881,967.411,945.921,977.621,889.761,784.981,954.932,034.37
Net Current Assets1,076.941,271.822,086.052,941.712,477.973,163.543,985.494,165.852,672.991,563.58
Deferred Tax Assets475.611,160.251,137.471,118.721,081.341,063.231,056.45820.62589.4124.84
Deferred Tax Liability309.77213.5214.2265.43276.6351.1395.83226.56188.25157.23
Net Deferred Tax165.84946.75923.27853.29804.74712.13660.62594.06401.16-132.39
Other Assets7,648.377,001.77,167.546,011.277,197.086,320.983,397.523,721.921,511.43868.49
Total Assets23,809.8521,471.2620,597.6218,650.1117,005.6815,165.0813,375.1112,215.568,158.085,484.07
Contingent Liabilities2,658.493,443.33,325.063,730.174,430.593,680.944,549.63,720.764,594.015,326.65

Cash Flow (Figures in Rs. Crores)

Net Profit before Tax and Extr...569.19
Depreciation630.81
Interest (Net)500.14
P/L on Sales of Assets-0.83
P/L on Sales of Invest-7.05
Prov. and W/O (Net)68.38
P/L in Forex-342.59
Total Adjustments (PBT and Ext...1,009.81
Operating Profit before Workin...1,579
Trade and 0ther Receivables969.51
Inventories-513.86
Trade Payables-734.41
Total Adjustments (OP before W...-796.95
Cash Generated from/(used in) ...782.05
Direct Taxes Paid-1,047.49
Total Adjustments(Cash Generat...-1,047.49
Cash Flow before Extraordinary...-265.44
Net Cash from Operating Activi...-265.44
Purchased of Fixed Assets-898.38
Sale of Fixed Assets2.08
Sale of Investments7.05
Interest Received17.16
Cancellation of Investment in ...5,449.61
Net Cash used in Investing Act...4,386.82
Proceeds from Issue of shares ...1.2
Proceed from Short Tem Borrowi...481.12
Of the Long Tem Borrowings-3,649.49
Of Financial Liabilities-104.43
Dividend Paid-117.75
Interest Paid-516.78
Net Cash used in Financing Act...-3,906.13
Net Profit before Tax and Extr...7,000.75
Depreciation202.16
Interest (Net)103.58
Dividend Received228.39
P/L on Sales of Assets0.25
P/L on Sales of Invest-7.05
Prov. and W/O (Net)33.39
P/L in Forex-173.41
Total Adjustments (PBT and Ext...-5,884.79
Operating Profit before Workin...1,115.96
Trade and 0ther Receivables-63.2
Inventories-147.52
Trade Payables-272.03
Total Adjustments (OP before W...-740.31
Cash Generated from/(used in) ...375.65
Direct Taxes Paid-871.1
Total Adjustments(Cash Generat...-871.1
Cash Flow before Extraordinary...-495.45
Net Cash from Operating Activi...-495.45
Purchased of Fixed Assets-195.11
Sale of Fixed Assets0.5
Sale of Investments7.05
Interest Received278.45
Invest.In Subsidiaires-9.05
Loans to Subsidiaires-2,562.51
Cancellation of Investment in ...5,449.61
Net Cash used in Investing Act...3,197.17
Proceeds from Issue of shares ...1.2
Proceed from Short Tem Borrowi...150
Of the Long Tem Borrowings-2,449.18
Of Financial Liabilities-35.63
Dividend Paid-70.45
Interest Paid-262.39
Net Cash used in Financing Act...-2,666.45

Company Details

Registered Office
AddressB/2 Mahalaxmi Chambers,
22 Bhulabhai Desai Road
CityMumbai
StateMaharashtra
Pin Code400026
Tel. No.91-22-40189999
Fax. No.91-22-40189986
Emailcomplianceofficer@glenmarkpharma.com
Internethttp://www.glenmarkpharma.com
Registrars
AddressB/2 Mahalaxmi Chambers
CityMumbai
StateMaharashtra
Pin Code400026
Tel. No.91-22-40189999
Fax. No.91-22-40189986
Emailcomplianceofficer@glenmarkpharma.com
Internethttp://www.glenmarkpharma.com
Management
Name Designation
Glenn SaldanhaChairman & Managing Director
Cheryl PintoExecutive Director (Corporate)
V S ManiExecutive Director & Group CFO
B E SaldanhaNon Executive Director
Rajesh Desai.Independent Non Exe. Director
Sona Saira RamasastryIndependent Non Exe. Director
Dipankar BhattacharjeeIndependent Non Exe. Director
V R IyerIndependent Non Exe. Director